Your browser doesn't support javascript.
loading
Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease.
Truitt, Kenneth E; Daveson, A James M; Ee, Hooi C; Goel, Gautam; MacDougall, James; Neff, Kristin; Anderson, Robert P.
Affiliation
  • Truitt KE; ImmusanT, Inc., Cambridge, Massachusetts, USA.
  • Daveson AJM; University of Queensland, Brisbane, Queensland, Australia.
  • Ee HC; Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
  • Goel G; ImmusanT, Inc., Cambridge, Massachusetts, USA.
  • MacDougall J; Prometrika, LLC, Cambridge, Massachusetts, USA.
  • Neff K; ImmusanT, Inc., Cambridge, Massachusetts, USA.
  • Anderson RP; ImmusanT, Inc., Cambridge, Massachusetts, USA.
Aliment Pharmacol Ther ; 50(5): 547-555, 2019 09.
Article in En | MEDLINE | ID: mdl-31407810

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Drugs, Investigational / Celiac Disease / Glutens Type of study: Clinical_trials Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2019 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Drugs, Investigational / Celiac Disease / Glutens Type of study: Clinical_trials Limits: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2019 Document type: Article Affiliation country: United States Country of publication: United kingdom